Professor Giorgi Eliava and the Eliava Institute of Bacteriophage.

Phage (New Rochelle)

School of Arts and Sciences, Ilia State University and Georgia Field Office, American Councils for International Education, Tbilisi, Georgia.

Published: June 2022

In the history of medicine little is known about Prof. Giorgi (George) Eliava, who must be recognized as one of the central figures in the story of bacteriophages. Today it may be said without any exaggeration that without the support that Eliava provided to Felix d'Herelle, much of our knowledge about phage therapy would never have been acquired. Eliava played a central role in developing and promoting therapeutic uses of bacteriophages in the Union of Soviet Socialist Republics and beyond, and it was largely due to his efforts-and the institute that he established-that phage therapy survived in Soviet Georgia during the Cold War when it was largely abandoned in the West. Because of his progressive thinking, tireless activities, and close collaborations with many foreign scientists, including d'Herelle, Eliava became a victim of Stalin's regime in 1937, declared an "Enemy of the People" and executed. Most photographs and documents belonging to Eliava were destroyed by the Committee for State Security (), so it is difficult to ascertain many of the details of his life, and his scientific activities are largely unknown. His memory was restored only after the reassessment of the outcomes of the Great Terror and Stalin's regime in later periods. In this article, we bring the remarkable but little-known story of Giorgi Eliava to a wide readership and thus pay tribute to his talent and his dedication to science, and celebrate his contributions to phage research and phage therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436386PMC
http://dx.doi.org/10.1089/phage.2022.0016DOI Listing

Publication Analysis

Top Keywords

phage therapy
12
eliava
8
giorgi eliava
8
stalin's regime
8
professor giorgi
4
eliava eliava
4
eliava institute
4
institute bacteriophage
4
bacteriophage history
4
history medicine
4

Similar Publications

The increasing threat of antimicrobial-resistant bacteria, particularly Staphylococcus aureus, which rapidly develops multidrug resistance and commonly colonizes wound surfaces, demands innovative strategies. Phage-encoded endolysins offer a dual-purpose approach as topical therapies for infectious skin wounds and synergistic agents to reduce high-dose antibiotic dependence. This study explores recombinant CHAPk (rCHAPk), efficiently synthesized within 3 h, displaying broad-spectrum antibacterial activity against 11 Gram-positive strains, including resistant variants, with rapid bactericidal kinetics.

View Article and Find Full Text PDF

Background: Oral infectious diseases, such as dental caries, periodontitis and periapical periodontitis, are often complicated by causative bacterial biofilm formation and significantly impact human oral health and quality of life. Bacteriophage (phage) therapy has emerged as a potential alternative with successful applications in antimicrobial trials. While therapeutic use of phages has been considered as effective treatment of some infectious diseases, related research focusing on oral infectious diseases is few and lacks attention.

View Article and Find Full Text PDF

The non-nutritive sweetener rebaudioside a enhances phage infectivity.

Sci Rep

January 2025

Department of Nutritional Biochemistry, University of Hohenheim, Garbenstraße 30, 70599, Stuttgart, Germany.

Non-nutritive sweeteners (NNS) are widely employed in foodstuffs. However, it has become increasingly evident that their consumption is associated with bacterial dysbiosis, which, in turn, is linked to several health conditions, including a higher risk of type 2 diabetes and cancer. Among the NNS, stevia, whose main component is rebaudioside A (rebA), is gaining popularity in the organic food market segment.

View Article and Find Full Text PDF

Using BW25113 as a host, we isolated a novel lytic phage from the commercial poly-specific therapeutic phage cocktail Sextaphage (Microgen, Russia). We provide genetic and phenotypic characterization of the phage and describe its host range on the ECOR collection of reference strains. The phage, hereafter named Sxt1, is a close relative of classical coliphage T3 and belongs to the genus, yet its internal virion proteins, forming an ejectosome, differ from those of T3.

View Article and Find Full Text PDF

Anti-phage defense systems are widespread in bacteria due to the latter continuous adaptation to infection by bacteriophages (phages). has a high degree of intrinsic antibiotic resistance, which makes phage therapy relevant for the treatment of infections caused by this species. Studying the array of anti-phage defense systems that could be found in helps in better adapting the phages to the systems present in the pathogenic bacteria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!